Clinical Trial Update: A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for MK-3009 in Japanese patients with MRSA-related skin and bloodstream infections; results for MK-3009-002 were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Methicillin-resistant Staphylococcus Aureus Infection
• Skin and Soft Tissue Infection

Drugs mentioned

• MK-3009

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Staphylococcal Infection | Phase 3 | Status: COMPLETED | Results posted: 2011-06-15